The company anticipates sales of $313.6 million, up 7.9 percent from last year’s $290.5 million in net sales. Preliminary fourth quarter sales for the company’s surgical implants business grew 22.2 percent over the fourth quarter of 2012.
More Articles on Devices:
Device Companies — 6 Key Notes — NuVasive, Aurora Spine & More
Titan Spine Gains 5 Patents for Endoskeleton Interbody Devices
Budgetary Fund Could Pay to Eliminate Medical Device Tax
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
